Clin2
NCT06218056Possibly a fitRecruiting

CBD for reducing cigarette smoking in a treatment center

Tobacco Use DisorderTobacco SmokingTobacco Dependence

Treatments studied

Part of Mental health clinical trials.

This study tests whether a daily dose of cannabidiol (CBD) can help people who smoke at least 5 cigarettes a day cut down or quit. It is for people staying at a treatment center in Los Angeles where cannabis use is not allowed.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
120 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old.
  • You smoke at least 5 cigarettes a day and want to quit.
  • You do not vape nicotine.
  • You are not physically dependent on alcohol or other drugs needing medical detox.
  • You are not taking buprenorphine or methadone for opioid use disorder.
  • You do not have schizophrenia, bipolar I disorder, or a psychotic disorder, and have not had suicidal thoughts or attempts in the past year.
  • You do not have AIDS or take HIV medication.
  • You are not pregnant or breastfeeding, and are willing to use contraception during the study.
  • You are not taking medications that interact with CBD (like some seizure drugs, blood thinners, or certain antidepressants).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05445804Recruiting· Phase 1
Oral cannabidiol (CBD) to help you quit tobacco

This Phase 1 study tests whether taking oral CBD can help people quit tobacco. It also checks safety and helps researchers learn how people respond to the treatment while they practice quitting.

Baltimore, Maryland
NCT07001930Recruiting· Phase 1
Cannabidiol effects on stress and nicotine withdrawal

This trial tests whether a cannabis-derived compound called cannabidiol (CBD) can help people who smoke cigarettes cope with stress and withdrawal symptoms when they stop smoking. CBD is not the part of cannabis that makes you high.

Baltimore, Maryland
NCT06883162Recruiting· Phase 3
A study to help people stop smoking tobacco and reduce cannabis use

This study tests whether a medication called varenicline (or a placebo) can help people who use both tobacco and cannabis to quit or cut back. It takes place in South Carolina and lasts 12 weeks.

Charleston, South Carolina
NCT07636356Not yet recruiting· Phase 2
THCV to help smokers quit cigarettes

This study tests whether a cannabis-derived compound called THCV can help people who smoke cigarettes regularly quit or cut back. You'll take THCV under medical supervision and your smoking habits will be tracked over time.

NCT06239350Recruiting
Young adult tobacco and cannabis co-use study

This study tests a program to help young adults who use both nicotine and cannabis products reduce or quit nicotine use. If you are between 18 and 25, use nicotine products at least 20 days a month and cannabis at least 10 days a month, and want to quit nicotine, you may be eligible.

Charleston, South Carolina
NCT06688539Recruiting· Phase 4
Quitting e-cigarettes in adults who also use cannabis

This trial tests if varenicline, a stop-smoking medication, can help people ages 18 to 40 quit e-cigarettes while also using cannabis. It's designed for regular e-cigarette users who want to quit and who use cannabis at least 10 days per month.

Charleston, South Carolina

Hear when a new Tobacco Use Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.